|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Alirocumab significantly reduced other lipid/lipoproteins (including lipoprotein[a]) similarly in patients with/without MI/ischemic stroke.
|
31076261 |
2020 |
|
Ischemic stroke
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Causal Effect of Lp(a) [Lipoprotein(a)] Level on Ischemic Stroke and Alzheimer Disease: A Mendelian Randomization Study.
|
31597550 |
2019 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
The purpose of this study was to test if high lipoprotein(a) is associated with high risk of ischemic stroke observationally and causally from human genetics.
|
31272552 |
2019 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) and Risk of Ischemic Stroke in the REGARDS Study.
|
30786745 |
2019 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Lipoprotein (a) as a Predictor of Early Stroke Recurrence in Acute Ischemic Stroke.
|
28004340 |
2018 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Elevated Lipoprotein (a) and Risk of Poor Functional Outcome in Chinese Patients with Ischemic Stroke and Type 2 Diabetes.
|
29264843 |
2018 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Case report of male child with elevated lipoprotein (a) leading to acute ischemic stroke.
|
28139007 |
2017 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Lipoprotein(a) Levels and Recurrent Vascular Events After First Ischemic Stroke.
|
27856951 |
2017 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Elevated serum lipoprotein(a) as a risk factor for combined intracranial and extracranial artery stenosis in a child with arterial ischemic stroke: A case report.
|
29245288 |
2017 |
|
Ischemic stroke
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study.
|
29246963 |
2017 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
The 2 LPA variants were combined and examined as LPA scores for the association with ischemic stroke (and TOAST [Trial of Org 10172 in Acute Stroke Treatment] subtypes) (effective sample size [n(e)] = 9,396); peripheral arterial disease (n(e) = 5,215); abdominal aortic aneurysm (n(e) = 4,572); venous thromboembolism (n(e) = 4,607); intracranial aneurysm (n(e) = 1,328); CAD (n(e) = 12,716), carotid intima-media thickness (n = 3,714), and angiographic CAD severity (n = 5,588).
|
22898070 |
2012 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Raised lipoprotein (a), protein C deficiency, and stroke of vascular origin are risk factors for recurrent arterial ischaemic stroke in childhood.
|
12443591 |
2002 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Available evidence indicates that factor V Leiden, prothrombin 20210A, and lipoprotein (a) are all important in the pathogenesis of arterial ischemic stroke in older children, but the role of other plasma-phase risk factors remains uncertain.
|
11923626 |
2002 |
|
Ischemic stroke
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Apolipoprotein(a) size polymorphism in young adults with ischemic stroke.
|
9920527 |
1999 |
|
Ischemic stroke
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
While FV G1691A and prothrombin G20210 A mutations show no significant data in our study, lipoprotein (a) levels >30 mg/dl protein C deficiency, anticardiolipin antibodies and combined prothrombotic disorders seem to be important risk factors for manifestation of ischaemic strokes in children with underlying cardiac disorders.
|
10650850 |
1999 |
|
Ischemic stroke
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood.
|
10572079 |
1999 |
|
Ischemic stroke
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Plasma lipoprotein(a) levels in subjects attending a metabolic ward. Discrimination between individuals with and without a history of ischemic stroke.
|
8548412 |
1996 |
|
Ischemic stroke
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Over a 2-year period the Arg506 to Gln mutation, factor V, protein C, protein S, antithrombin, antiphospholipid antibodies and lipoprotein (a) [Lp(a)] were measured in 14 infants and children with acute ischaemic stroke.
|
8958390 |
1996 |
|
Ischemic stroke
|
0.100 |
Biomarker
|
disease |
BEFREE |
Lipoprotein and apolipoprotein profile in men with ischemic stroke. Role of lipoprotein(a), triglyceride-rich lipoproteins, and apolipoprotein E polymorphism.
|
1440702 |
1992 |